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Summary 
Rather unexpectedly,  major histocompatibility complex class  II-deficient mice have a signifi- 
cant population  of peripheral  CD4 +  T  lymphocytes. We  have investigated  these  cells  at  the 
population and clonal levels.  CD4 + T  lymphocytes from class II-deficient animals are thymi- 
cally derived, appear early in ontogeny, exhibit the phenotype of resting memory cells,  are po- 
tentially functional by several criteria,  and have a diverse T  cell receptor repertoire.  They do 
not include  substantially  elevated  numbers  of NKI.1 §  cells.  Hybridomas  derived  after poly- 
clonal stimulation  of the  CD4 + lymphocytes from class  II-deficient animals include  a  subset 
with an unusual reactivity pattern,  responding to splenocytes from many mouse strains includ- 
ing the  strain  of origin.  Most members  of this  subset  recognize the  major histocompatibllity 
complex class Ib molecule CD1; their heterogenous reactivities and T  cell receptor usage fur- 
ther suggest the involvement of peptides and/or highly variable posttranslational modifications. 
M 
ost CD4 + T  cells depend on an interaction with the 
MHC  class II molecules expressed on thymic stroma 
to  complete  differentiation.  As  a  consequence,  mice  that 
lack the  conventional class  II molecules  (II  ~ mice) 1 have a 
drastic reduction in the number of mature CD4 + T  cells in 
the  thymus and peripheral  lymphoid organs  (1-3).  Unex- 
pectedly, though,  a small population of CD4 + T  cells was 
detected  in  the  spleen  and lymph nodes  of these  animals. 
This  population  did not appear to result from nonspecific 
"leakage" because the cells had atypical properties: they ex- 
pressed  markers  reminiscent  of memory  cells  and  were 
preferentially localized in the B  cell areas  of lymphoid or- 
gans. 
The existence ofCD4 + T  cells in II  ~ mice contradicts pre- 
vious dogma on positive selection, which states that CD8 + 
cells  result  from a  TCtL/MHC  class  I  molecule  engage- 
ment in the  thymus and react in the  periphery to antigen 
presented  by class  I  molecules,  while  CD4 +  cells  emerge 
after a TCR/class II interaction and have class II-restricted 
antigen  reactivities  (reviewed  in  reference  4).  Since  the 
CD4 + cells in the II  ~ mice could not have been selected on 
1Abbreviations used in  this paper: BrdU, bromodeoxyuridine; ~2m  ~  J32 
microglobulin-deficient mice; Ii  ~ invariant chain deficient; II  ~ mice, mice 
that lack the conventional class II molecules; TAP, transporter associated 
with antigen processing. 
conventional  class  II  molecules,  several  questions  arose: 
When and where are these cells  generated? Does their cell 
surface  phenotype  show  other  atypical features?  Are  they 
functional? If so, what ligands do they recognize? Here, we 
address these questions at the population and clonal levels. 
Besides  determining  some important  general  properties  of 
the peripheral CD4 + T  cell population in II  ~ mice, we de- 
scribe  an  interesting  set  of hybridomas  derived  from this 
population. 
Materials and Methods 
Mice.  II  ~ mice (1), originally  on a mixed C57BL/6J 036) X 
129 background, were mostly from the fifth to eighth generation 
backcross to B6; invariant  chain-deficient mice (Ii  ~  (5) were on a 
mixed B6  ￿  129  background; B  cell-deficient  mice  (6), were 
bred  onto  the  nonobese  diabetic  (NOD)  genetic  background; 
]32-microglobulin-deficient mice  ([32m  ~  (7)  were  on  a B6  ￿ 
129 background. Most mice were maintained in specific patho- 
gen-flee  conditions  at  the  Centre  de  Selection  d'Animaux de 
Laboratoire (Orleans,  France).  DBA/2J, 129, and NOD/Lt mice 
were  bred  in  our  animal  facilities.  The  BALB.Mls  ~ congenic 
strain  carries  the  Mls  a locus  (Mtv-7)  of DBA/2  mice  on  the 
BALB/c  genetic  background  and  was  obtained  thanks  to  1K. 
Zinkernagel  (Institute  for  Experimental  Immunology,  Ziirich, 
Switzerland)  and IK. McDonald (Ludvig Institute  for Cancer IKe- 
search,  Epalinges,  Switzerland).  Mice deficient in the transporter 
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129 background) were provided by Drs.  A. Berns (The Nether- 
lands Cancer Institute, Amsterdam, The Netherlands), H. Ploegh, 
and H. Van Santen (Massachusetts  Institute of Technology, Cam- 
bridge, MA). BALB/cBy and C3H/He mice were purchased from 
1FFA-CREDO  (L'Arbresle,  France);  B10.BR.,  B10.A(4R.), 
B10.D2, B10.S, B10.M, B10, and BALB.B mice were from Har- 
lan Olac (Oxon, England); and SJL, B6.Tla  a, and B6 mice were 
from The Jackson Laboratory (Bar Harbor, ME). The strains de- 
rived from  wild mice Mus  spretus (SEG),  Mus spicilegus (Zt-ZU), 
Mus  musculus castaneus (CTA), and Mus  macedonicus (XBS)  were 
kind gifts from Dr. F. Bonhomme (Universit4 de Montpellier II, 
Montpellier, France). 
Flow Cytometry.  Single  cell  suspensions  were  stained  with 
mAbs  of the  following specificities: KT3  (CD3e),  KT4  (V134), 
MR9-4  (V]35), 44.22.1  (V136), KJ16  (V]38.1/8.2),  RR3.15 
(V[31 l), IM7 (CD44), H57-597 (TCtKc~]3), for references see (1), 
MR10-2 (V139 [8]), B21.5 (VIII0 [9]), B20.1.1  (Vot2 [10]), KT50 
(Vot8 [11]),  M17/4 (LFA-lo~ [12]), YN1/1.7.4 (ICAM-I/CD54), 
MEL-14  (L-selectin/CD62L [13]),  16A  (CD45RB  [14]),  PC61 
(CD25 [15]), PKl36 (NKI.1 [16]), and 12-15A-biotin (CD2 [ 17]). 
Before  cells  from  newborn and young mice were  stained,  they 
were incubated with the 2.4G2 cx-FcyR antibody (18)  to block 
nonspecific background staining. Labeled cells were analyzed on 
FACScan  |  (Becton  Dickinson  &  Co.,  Mountain  View,  CA), 
ODAM  ATC  3000  (Bruker  Spectrospin,  Wissembourg,  Ger- 
many), or Coulter Epic Elite (Coulter Corp., Hialeah, FL)  flow 
cytometers, and sorted using the ATC or Elite. 
Intrathymic FITC Injections.  Intrathymic FITC injections were 
performed as described (19).  Both thymic lobes of the 5-wk-old 
mice were injected with 10 txl of 1 mg/ml FITC in PBS. 24-36 h 
later,  thymus and lymph node  cells  were  prepared  and stained 
with c~-CI)4 and c~-CD8 reagents.  The level of FITC label on 
thymocytes was analyzed to evaluate the efficiency of intrathymic 
injection, and only successfully injected mice were analyzed fur- 
ther. Events of each sample were collected ungated, and gated for 
CD4 + and CD8 + cells  (at  least  50-100  X  103 events per gated 
population), and analyzed for frequencies of FITC  + cells.  Cells 
from noninjected or intrathorax-injected (19) mice were used as 
negative controls. 
Bromodeoxyuridine (BrdU) Labeling.  0.8 mg BrdU in PBS was 
injected intraperitoneally into mice every 12 h for 2 d.  12 h after 
the last injection, mice were killed and lymph node cells were pre- 
pared. The cells were fixed first in 70% EtOH, then 1% paraform- 
aldehyde, and stained with CD4-PE and CD8-biotin followed by 
streptavidin-cytochrome,  then  stained  to  detect  incorporated 
BrdU  after  a  modification  (20)  of (21)  using anti-BrdU-FITC 
(Becton Dickinson). 
T  Cell Activation.  Spleen and lymph node cells  were pooled 
and depleted of B  cells  by panning with polyclonal rabbit anti- 
mouse Ig antibodies coated on plastic petri dishes, and then de- 
pleted of CD8 + cells after labeling with CD8-biotin and strepta- 
vidin-magnetic beads using the MACS (magnetic cell separation) 
magnet (Miltenyi Biotec, Bergish-Gladbach,  Germany), follow- 
ing the  manufacturers instructions.  The  cells  were  then  sorted 
twice for CD4 + cells,  resulting in a  >95% pure population. In 
some experiments, the depletion steps  were omitted. The sorted 
CD4 + cells were stimulated at 1.5-3 X  104 cells per well in anti- 
CD3-coated  (KT3 antibody coated at 5  Ixg/ml or as indicated) 
round-bottom,  96-well  plates  in  Hepes-buffered  RPMI  1640 
medium containing glutamine supplemented with  10%  FCS, 20 
IxM 2-ME, 1 mM Na-pyruvate, and penicillin/streptomycin. 2 d 
later, the wells were pulsed with 1 IxCi [3H]TdR and were hat- 
vested 16-20 h later. The amount of incorporated [3H]TdR was 
measured in a gas scintillation Matrix Direct Beta Counter 9600 
(Packard  Instrument Co.,  Meriden,  CT)  with  a  counting effi- 
ciency of 25% compared with liquid scintillation counting. 
AnalFsis of Lymphokine Production.  At the indicated times dur- 
ing in vitro stimulation, supernatants were harvested and dilutions 
were  added to  104 CTLL cells  per well.  After 24  h  of culture, 
wells were pulsed with 1 I.LCi [3H]TdR for 3-6 h and harvested. 
IL-4 and IFN-y were quantitated in an ELISA using the BVl)4- 
11)11 (anti-IL-4) or AN-18 (anti-IFN-y) antibodies to coat 96-well 
plates, followed by incubation with dilutions of culture superna- 
tant. Bound lymphokine was  revealed by a biotinylated second 
IL-4  (BVD6-24G2)-  or  IFN-y  (R4-GA2)-specific  antibody, 
streptavidin-alkaline phosphatase and the  euzyme substrate  (104 
phosphatase substrate tablets; Sigma hnnmnochemicals, St.  Lonis, 
mo). 
7" Cell Hybridomas.  After 4-5 d of stimulation by plate-bound 
anti-CD3,  CD4 +  T  cell  blasts  were  fused  with  TCP,-{x--]3- 
BW5147 cells (22) according to standard protocols (23).  Growing 
hybridomas were stained for TCR and (2I)4 expression, and only 
double-positive hybridomas were  used  for  further  analysis.  For 
subsequent hybridoma stimulation assays, 3-5  X  1()  4 hybridoma 
cells  were  cultured in 200  ILl medium (supplemented as above) 
together with graded numbers of spleen (40-5 X  104 per well) or 
cell line (40-5 X  103 per well) stinmlator cells. Anti-CD3 stimu- 
lation (see above) was used as a positive control. After 15-20 tl, 
IL-2 release  was evaluated in a CTLL assay as described above. 
Cell Lines.  L cells  expressing Qa-l" (as a eDNA  of the T23 
gene, clone 18.6.2A1  (24),  T1012v (25),  or T2212') genes (25), and 
RMA cells expressing CDI.1 (Teitell, M., H.R. Holcombe, M.J. 
Jackson, L. Pond, S. P. Balk, C. Terhorst, P.A. Peterson, and M. 
Kronenberg, manuscript subnfitted for publication) and the  TL 
antigen (encoded by the TI8  a gene [see reference 26]) were used 
to  stinmlate hybridomas as described above.  Transfections of L 
cells were made with Qa-1 b- (24) and CD1.1- (Teitell, M., et al., 
manuscript submitted for  publication)  encoding plasmids  using 
the calcium phosphate precipitation method. 
TCR Sequencing.  PCP,, sequencing of TCR-{~ and -13 cl)NAs 
from sorted populations of CD4 §  cells  or from  hybridomas was 
perfornled after amplifcation with degenerate V{* and V13 prim- 
ers as detailed previously (27).  For Vot14-specific amplifications, 
the  V  region primer was  5'-GTCCTGACCTCGCATGCGA- 
CAACCACTTAAGGTGGTTC. 
Results 
A  Peripheral  Population  of CD4  +  T  Cells  Independent  OF 
Conventional Class I and 11 Molecules.  In adult II  ~ mice, 5- 
15% of the usual number ofCD4 + cells can be found in the 
spleen and lymph nodes  (Fig.  1 A),  and 90%  of these  ex- 
press the ot]3 TCR  (references 1-3 and data not shown). As 
previously discussed  (I),  the  simplest explanation for  such 
cells is  that  they were  positively selected on MHC  class  l 
molecules.  To  test this,  we  crossed  the  II  ~ line with  mice 
deficient in class  I  expression because  of a  disrupted  132m 
gene  (7).  The double mutants had a  peripheral population 
oFCD4 + cells similar in numbers and phenotype to that of 
II  ~ animals  (Fig.  1  and  data  not  shown).  Such  cells  were 
also present in B  ceH-deficient/II  ~ mice  (data not shown), 
ruling out a dependence on molecules expressed on B  cells, 
such as Igs or superantigens, as well as in Ii~  ~ animals, ar- 
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Figure 1.  Peripheral  CD4  + T cells in MHC class lI-deficient mice were not dependent on class I molecules. Lymph node cells from wild-type, class 
lI-deficient (II~  and 1~2m/class II double-deficient  (I~  ") littermate  mice were stained for the CD4 and CD8 markers. Dot plots show typical distribu- 
tions in several animals  analyzed. The numbers show the percentage of CD4  + cells in the indicated gates. The total number of cells in spleen or lymph 
nodes of the two mutants did not vary significantly  from the wild type. 
guing against their selection on a nonconventional  class II- 
like molecule (Viville, S.,  C.  Benoist, and D.  Mathis, un- 
published observation). 
Population  Dynamics  of the CD4 + T  Cells in 11 ~ Mice.  To 
study  the  ontogeny  of this  unusual population,  we  fol- 
lowed  the  appearance  of CD4+CD3 +  cells  in the  spleen 
and mesentefic lymph nodes of mutant and control animals 
from the  1st  d  after birth. A  CD4+CD3 +  population was 
clearly detectable in the two organs of both types of mice 
during the  1st  wk  of life.  In both  cases,  the  number of 
CD4+CD3 +  cells  increased  N10-fold  during  the  subse- 
quent 2 wk (quantitated in the spleen; Fig. 2). Once estab- 
lished,  the  II  ~ CD4 +  population was  maintained without 
changing size, even in mice >1 yr old (not shown). 
We next sought to determine whether the CD4 + cells in 
II  ~ mice originate in the thymus (19). Thymocytes from 5 
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Figure 2.  Early  appearance of CD4 + CD3 + cells in the spleen of II  ~ 
and control II  + mice. On the indicated days, spleen cells were prepared 
from mixed litters of II  ~ and wild-type heterozygote control mice, and 
they were analyzed  for CD4, CD8, and CD3 expression. Each dot repre- 
sents pooled cells or the mean value from at least three litterrnates  oflI  ~  or 
II  + phenotype. 
wk-old mutant and control mice were  marked in situ by 
intrathymic injection of FITC.  30  h  later,  lymph  nodes 
were analyzed for the presence of thymus-derived, FITC- 
labeled cells (Fig. 3 A). CD4 + and CD8 + cells from control 
animals and CD8 + cells from mutants were all labeled to a 
similar  extent.  FITC  +  early  thymic  emigrants were  also 
readily  detectable  among lymph  node  CD4 +  cells  in  II  ~ 
mice, albeit at frequencies slightly lower than that of con- 
trol  CD4  +  and CD8 +  cells. The rate  of export of CD4 + 
cells from the  II  ~ thymus was ,'ol/50 of the  control thy- 
mus, allowing an approximation of 1-2  X  104 cells per d 
(19). 
To determine the proportion of cycling cells in the es- 
tablished CD4 §  population, we  exposed control and mu- 
tant mice to BrdU confnously for 48 h. As for the control 
II  +  (MHC class II-positive) mice, only a small proportion 
of lymph node  CD4  +  cells in  II  ~ mice had  incorporated 
BrdU during the labeling period (5-11%; see Fig. 3  B), in- 
dicating that only a minor fraction was actively dividing. 
Altogether,  these  data  indicate  a  stable  population  of 
CD4 + T  cells in II  ~ mice. Its thymic input rate and prolif- 
erative turnover rate are not markedly different from those 
exhibited by the CD4 + T  cells of wild-type animals. 
Cell  Surface  Marker  Profiles.  The  initial description  of 
CD4 + T  cells in II  ~ mice indicated atypical cell surface an- 
tigen profiles: reduced levels of CD3/TCR  and high levels 
of CD44.  We  extended this phenotypic analysis by using 
several additional antibodies that  detect T  cell differentia- 
tion and activation markers (Fig. 4). 
The cells expressed normal levels of the T  cell markers 
CD2 and CD28  (Fig. 4),  as well as  CD5 and Thy-1  (not 
shown).  In contrast to  control CD4  +  T  cells,  75-80% of 
the CD4 + cells from mutant mice had a phenotype charac- 
teristic  of  memory  cells  (for  review,  see  reference  28): 
CD45RB  l~  CD62L-  and  increased  levels  of  CD54 
(ICAM-1) and CD11a (LFA-1). Nevertheless, the majority 
of cells were in a resting state as evidenced by generally low 
995  Cardell et al. | 
Uninjected 
control 
II + 
FITC 
II  ~ 
FITC 
CD4 + cells 
FITC 
CD8 + cells 
t  I~ 
%  o FITC-positive within 
I  I 
CD4+cells  CD8+cells 
Mouse #  (gate F)  (gate G) 
1  0.02  0.00 
2  0.03  0.20 
3  0.00  0.00 
4  8.4  7.8 
5  7.6  7.6 
6  5.2  4.0 
7  2.4  4.7 
8  2.4  6.7 
9  2.3  7.6 
10  3.5  4.8 
| 
5.5% 
"'7 
II 
l;  11.1% 
BrdU 
Figure 3.  Thymic output and proliferative  turnover ofCD4 + ceils in II  ~ and control nfice. (A) Thymocytes of 5-wk old II  ~ and II + mice were labeled 
in situ by injection of FITC into the thymus. 30 h later, lymph node cells were stained and analyzed for the presence of FITC-positive CD4 + and CD8 + 
cells. The histograms show representative green fluorescence  profiles of gated CD4 + or CD8 + cells from an uninjected control mouse,  as well as FITC- 
injected II + and II  ~ mice. Gates for FITC-positive cells were set as shown (gates G and F), and values (0/00 =  number of cells per thousand) from three 
to four individual mice in each group are shown on the right. (B) Adult mice were injected with BrdU at 12-h intervals during 2 d. Lymph node cells 
were stained for incorporated BrdU, CD4, and CD8 expression,  and they were analyzed for the frequency of BrdU-labeled cells in each population. The 
histograms show BrdU staining of gated CD4 + cells from control and II  ~ mice. 
CD69  and  CD25  expression.  The  fraction  of CD69-ex- 
pressing  CD4 +  cells  in  II  ~  mice  was  somewhat  elevated 
(20-30%,  compared  with  5-10%  in  II +  CD4 +  cells),  but 
still represented  only a  minority of the population,  consis- 
tent with the cell cycle analysis mentioned  above. 
An  unusual  population  of thymocytes  and peripheral  T 
lymphocytes  has  recently  been  described.  These  cells  are 
positive  for  the  NKI.1  marker  (29,  30),  their  selection  is 
132m  dependent  (31-34),  and  they  preferentially  express 
certain  V(x  and  VI3  segments  (29,  30,  35-37).  The  fre- 
quency  of CD4 +  cells  expressing  the  NKI.1  marker  was 
higher in lI  ~ than II +  mice:  15-25%  of the  CD4 +  cells in 
spleen or lymph node in II  ~ mice were positive, while only 
2-6%  of control CD4 +  cells were.  However,  given that II  ~ 
mice have  10-20-fold fewer CD4 +  cells than II +  mice, the 
absolute  number  of NKI.1 +  CD4 +  cells  in  both  animals 
was  similar,  a  finding  in  agreement  with  previous  results 
(32-34). We  conclude,  therefore, that the NKI.1 + popula- 
tion  is  only  a  subset  of the  CD4 +  cells  in  II  ~  mice.  This 
point is further substantiated by the broad TCR  repertoire 
ofCD4  +  cells in II  ~ mice (see below). 
Functional  Potential.  The  next  priority  was  to  establish 
to  what  extent  the  CD4 +  T  cells  from  II  ~  mice  function 
like  normal  CD4  T  cells.  Purified  CD4 +  cells  from  both 
mutant  and  control  animals  proliferated  vigorously  in  re- 
sponse to plate-bound anti-CD3  (Fig. 5  A) or staphylococ- 
cal  enterotoxin  B  in  the  presence  of splenic  APCs  (not 
shown),  the II  ~ CD4 +  cells often slightly better.  Anti-CD3 
stimulation  also  led  to  upregulation  of the  early  activation 
markers  CD69  and  CD25  on  both  mutant  and  control 
CD4 +  cells (not shown). 
Stimulation with anti-CD3  induced the CD4+cells from 
CD2  CD28  CD45RG  GD45RB  CD62L  ICAM1 
t A  ....  IA  EL  IA 
LFA1 
A 
CD69  CD25  NKI.I 
Figure 4.  CD4 + T cells in class II  ~ animals display the phenotype of resting memory cells. Lymph node cells from adult II + and II  ~ mice were stained 
for CD4 and CD8 in combination with various  cell surface markers  as detailed  in Materials and Methods. Histograms,  representative of several experi- 
ments, show the expression  of the indicated markers  on gated CD4 + cells from both types of mice. A typical negative control is overlayed in the first 
panel on the left. 
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Figure  5.  Responsiveness of purified CD4 +  cells from class II  ~  and 
control mice. Sorted CD4 + cells were activated with plate-bound anti- 
CD3. (A) Proliferation.  Incorporation of [3H]TdlK was measured on days 
2-3.  (B) IL-2 production. After 24 h of culture, supernatants were har- 
vested and IL-2 production was estimated.  IL-2 production is presented 
as [3H]TdlK incorporation of the CTLL indicator cells. (C-) Kinetics  of 
IL 4 and IFN-'y production. After 4,  18, and 53 h of stimulation, super- 
natants were  harvested and  analyzed  for  IL-4  and  IFN-3~ content by 
ELISA. Relative amounts of cytokine are displayed as the read OD value 
for undiluted supernatant. 
II  ~ mice to produce  similar amounts of IL-2  (Fig. 5  B), and 
more  IL-3  (not shown),  IL-4  ,  and IFN-',/  (Fig.  5  C)  than 
CD4 +  cells  from  control  mice.  The  main  difference  con- 
cerned IL-4, quite abundant in mutant CD4 + cells but very 
low  to undetectable in wild-type  cells,  as expected for na- 
ive cells. Mutant-derived  CD4 +  cells secreted cytokines al- 
ready at 4  h; in both cases, the levels of IL-4 and IFN-~/in 
the supematant increased until day 2  (Fig.  5  C).  Strikingly, 
the IL-4/IFN-~/ratio  produced by the CD4 +  cells derived 
from  II  ~ animals was  several-fold higher than  that of con- 
trol CD4 +  cells. 
Furthermore, when  Th activity oflI ~ and control CD4 + 
cells  was  compared  in  a  nonspecific  B  cell  help  assay  in 
vitro,  purified  CD4 +  cells  from  mutant  and  control  mice 
induced B  cell proliferation to similar levels (not shown). 
Together,  these findings argue that the CD4 +  T  cells in 
II  ~ mice are functionally similar to  control CD4 +  cells but 
they secrete different ratios oflymphokines  when  activated. 
TCR  Repertoire.  The  TC1K  repertoire  displayed  by 
CD4 +  cells from II  ~ mice was  first investigated by quanti- 
tating  expression  of various  V[3s  and VoLs  on lymph  node 
cells.  Our  initial  studies  (1),  using  conventionally  housed 
mice  at  earlier  stages  of the  backcross  to  B6,  had  shown 
some  variability in V~  usage  between  individual II  ~ mice. 
This variability was not confirmed in the present study (Ta- 
ble  1).  CD4 +  cells in II  ~ mice  made broad use of V[3 seg- 
ments,  exhibiting an  overall pattern  comparable  with  that 
of CD4 +  cells in control littermates.  Some  differences  did 
emerge,  however.  V[35  and V[39  are much  rarer in CD4 + 
than  CD8 +  cells  of normal  mice  (Table  1  and  reference 
38);  these V[3s were found in greater proportions in CD4 + 
cells  of II  ~ animals.  Conversely V134  is  overrepresented  in 
CD4 +  vs CD8 +  cells  of normal  mice  (Table  1  and  refer- 
ence 39),  and was  used  at  a  low  frequency  in  CD4 +  cells 
from It  ~ animals.  There  are also a  few peculiarities specific 
Table  1.  TCR  V Region  Usage in H ~ and Control Lymph Node  T Cells 
V[34  V[35  V[36  V[38  V[39  V[310  V[311  V,x2  V~x8 
CD4 
II + 
II  ~ 
7.3  6.7  2.3  2.8  8.4  8.8  18.2  16.8  0.8  1.1  4.7  4.0  4.6  4.3  10.3  --  2.1  -- 
7.0  6.9  3.2  --  8.5  8.1  17.6  17.2  0.8  --  4.2  4.8  4.9  5.7  12.8  14.1  2.6  3.6 
2.2  2.7  7.0  8.9  5.8  6.1  19.9  17.6  2.1  3.2  1.8  2.3  4.2  3.4  --  2.8  --  1.1 
2.6  4.2  6.1  --  5.3  7.1  20.8  21.2  2.3  --  1.9  1.9  2.2  4.2  2.1  4.4  1.7  5.0 
CD8 
II + 
II  ~ 
3.8  3.4  14.7  14.2  6.7  7.6  16.8  16.8  2.7  2.3  4.5  4.9  6.4  6.2  7.1  --  3.0  -- 
3.6  3.6  15.9  --  7.1  6.7  16.4  16.0  2.4  --  4.7  4.4  6.6  7.3  8.1  8.7  4.3  6.3 
4.3  4.3  17.8  17.2  8.3  8.2  15.7  15.8  1.9  2.1  3.6  3.3  6.3  6.3  --  5.5  --  1.7 
4.3  4.7  17.9  --  8.6  9.2  16.5  16.1  1.9  --  3.4  3.3  6.0  6.9  7.2  8.6  3.3  6.9 
Lymph node cells from II  ~ and II + littermate control mice were stained and analyzed by flow cytometry for expression of the indicated TCR V seg- 
ments. The percentage of positive cells within gated CD4 + and CD8 + populations of individual II  + and II  ~ animals are shown. --, not done. Values 
in bold indicate >~2.5-fold difference in V segment representation (mean value) between 11 + and II  ~  CD4 + cells. 
997  Cardell et al. to  the  II  ~ CD4 +  population,  notably  the  low Vex2  usage. 
Overall,  the  pattern  of V  segment  usage  by  CD4 +  cells 
from mutant  mice was subtly different from that exhibited 
by conventional MHC  class I- or class II-restricted cells. 
Additional  evidence  that  the  II  ~  CD4 +  cells  display  a 
broad repertoire  was obtained  by sequencing  VDJ regions 
from  TCP,-]3  chains  (Bogue,  M.,  C.  Benoist,  and  D. 
Mathis,  unpublished  results).  V]38.2  chains  showed  a  high 
diversity  in  the  VDJ joining  region,  displaying  the  usual 
spectrum  of N  nucleotides, J  region  usage,  distribution  of 
CDP,3  lengths,  and amino acid composition in the CDP,3 
loop. 
High  Frequency of Autoreactive Specificities among Hybrido- 
mas from  H ~ Mice.  Since  the  CD4 +  cells  from  II  ~  mice 
represent  a  diverse  population  of  potentially  functional 
cells, it was of interest to identify their restricting (and pos- 
sibly  selecting)  elements.  We  tried  to  derive  allo-  or  au- 
toreactive hybridomas on the grounds that such reactivities 
might  give  us  a  clue  to  their  natural  restricting  elements, 
much as MHC  class II-directed allo- and autoreactive cells 
from normal mice reflect the class  II restriction  of the bulk 
of the CD4 + cells. To generate a panel of hybridomas, we 
purified  CD4 +  T  cells from several II  ~ and  II  + littermates, 
stimulated  them  with  anti-CD3,  and  fused  them  with 
TCR-~x-]3- BW5147  cells. We then challenged the hybri- 
domas with  splenocytes from several mouse strains,  differ- 
ing at MHC, minor histocompatibility,  and/or endogenous 
murine tumor virus loci. 
As indicated in Fig.  6, very few of the hybridomas from 
II  + littermates responded to any spleen cell stimuli, save for 
a scattered few whose reactivities correlated with H-2 hap- 
lotype  (e.g.,  XII44 and  XIV18,  reactive to  H-2  a)  or with 
endogenous  murine  tumor  virus  genes  (e.g.,  XII49  and 
XIV50,  Mlsa);  only one  (X17)  was  autoreactive  (Ab-reac  - 
tive).  The  reactivity  pattern  of  the  hybridomas  derived 
from II  ~ mice was very different: while there was no activa- 
tion  when  they were  cultured  alone,  >10%  responded  to 
syngeneic II  ~ spleen cells in the absence of any added anti- 
gen.  M1  of these  autoreactive  hybridomas,  which  origi- 
nated  from several  mice,  also  displayed  a  broad  reactivity 
pattern,  since  all  but  two  were  stimulated  by spleen  cells 
from every mouse strain tested.  This suggested a nonpoly- 
morphic  target,  clearly distinct  from classical MHC  class  I 
and II molecules. 
Recognition  of  Class l-like  Ligands  by  the  Autoreactive 
Hybridomas.  To investigate the nature of the nonconven- 
tional ligand(s)  recognized  by the polyreactive hybridomas 
derived from mutant mice, we selected  11  for further anal- 
ysis. Although a population of CD4 + T  cells was present in 
[32m~  ~ double-mutant  animals,  this did not entirely rule 
out peripheral reactivity to MHC  molecules,  and the non- 
polymorphic nature of the ligands was reminiscent of non- 
classical  MHC  molecules.  We  therefore  considered  the 
possibility  that  such  molecules,  either  class  II- or  class  I- 
like,  might  serve  as  ligands.  Their  expression  might  well 
depend,  for the former, on the Ii involved in trafficking of 
conventional  MHC  class  II molecules,  or for the latter,  on 
]32m.  We thus  tested the panel of hybridomas with spleen 
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cells from mutant Ii  ~ or [32m  ~ mice (5, 7). All of the hybri- 
domas  were  well  stimulated  by  Ii-deficient  APCs  (not 
shown),  while  Ii  ~ APCs  were  not  recognized  by  control 
Al'-reactive  hybridomas.  On  the  other  hand,  6  of the  11 
hybridomas  did  not  respond  to  splenocytes  from  132m  ~ 
mice  (Fig.  7).  This  encouraged  us  to pursue  the  idea  that 
nonpolymorphic  class  I-like  molecules  are  recognized  by 
the autoreactive hybridomas from II  ~ mice. 
Qa- 1 Recognized by One of the Autoreactive Hybridomas.  The 
reactivity  of  the  ]32m-dependent  hybridoma  VII11  ap- 
peared to correlate with the expression of the b allele of the 
class Ib molecule Qa-1  (Fischer-Lindahl,  K., personal com- 
munication).  For example,  as shown  in  Fig.  6,  splenocytes 
from  the  strains  C3H/He  (H-2  k)  and  B10.S  (H-2  ~)  both 
express  Qa-1 b  and  elicited  a  response,  while  those  from 
B10.BR.  (H-2 k)  and  SJL  (H-2  S)  show  Qa-1 a and  did  not. 
This correlation  was extended  by using a pair of congenic 
strains. B6 mice express the b  allele of Qa-1, while B6.Tla" 
animals are congenic for the T  region, including  the Qa-I 
encoding  T23 gene,  and carry the Qa-P  allele. B6 but not 
B6.Tla a spleen  cells were  well  recognized  by the  VII11.1 
hybridoma (not shown).  Finally, we directly tested whether 
Qa-1  was being recognized by stimulating the VII 11.1  hy- 
bridoma with  L  cells transfected  with  the  T2Y' gene  (24). 
The  hybridoma  responded  specifically to  transfectants  ex- 
pressing  Qa-1 b,  but  not  to  mock  transfected  cells  nor  to 
cells transfected with other Ib genes (Fig. 8). 
CD1  Recognized  by  the  Majority  of  the  Autoreactive 
Hybridomas.  For  the  other  autoreactive  hybridomas,  the 
reactivities depicted in Fig.  6 were too broad to give much 
clue as to the targets involved.  We could exclude  the class 
Ib molecule  Qa-2,  as  the  stimulating  ligand(s),  was found 
to be present  on  splenocytes  of B10.M  mice  (not shown) 
that carry a deletion encompassing the genes encoding sur- 
face-bound  Qa-2  (40).  Therefore,  we  tested  the  panel 
against a set of transfectants expressing other class  lb mole- 
cules:  the  T  region-encoded  antigens  TL  (26),  T22,  and 
T10  (25), and a molecule encoded outside the MHC, CD1 
(Teitell,  M.,  et al.,  manuscript  submitted  for publication). 
Both  the  ]32m-dependent  and  -independent  hybridomas 
were included in the screening because there is at least one 
example of a  class  Ib molecule  that shows variable depen- 
dence  on  [32m for surface  expression  (41).  The  results  are 
presented in Fig. 8. Strikingly, seven hybridomas, including 
two [32m-independent,  specifically recognized transfectants 
expressing CDI.I; these reactivities could be detected with 
CD1.1-transfected  1KMA or L cells (not shown). 
TAP-independent  Trqlficking of the Target Ligands. Peptide 
loading  and  surface  expression  of classical  MHC  class  l 
molecules  are  generally  dependent  on  the  TAP  molecule 
(see reference 42 and references therein),  but this is not al- 
ways the case for nonclassical class I molecules (43-45).  To 
determine  whether  the  ligands  recognized  by our unusual 
CD4 + T  hybridomas depend on the  TAP gene for expres- 
sion,  we stimulated  the panel with spleen  APC from mice 
carrying  a  debilitating  mutation  in  the  TAP-1  gene  (42). 
While  the  Qa-1  ligand  seen  by the  VIIll  hybridoma  re- 
quired  TAP  to  be  expressed,  none  of the  ligands  recog- 
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Figure  6.  Allostimulation  of CD4 +  hy- 
bridomas  derived  from  II +  and  II  ~ mice. 
Hybridomas  were  challenged with  splenic 
APC from the indicated mouse strains. After 
15-20 h  of culture, supernatants were har- 
vested  and  release  of IL-2  was  evaluated. 
Anti-CD3  stimulation was used as positive 
control  for  hybridoma  function  (not 
shown). Black boxes indicate positive reac- 
tion,  -  indicates a  negative reaction,  and 
empty boxes were not done.  None of the 
hybridomas secreted IL-2 in the absence of 
APC. The presented results are a compila- 
tion of several experiments. Correlating loci 
are indicated on the right. The A b specificity 
of VII75  and X17  has been  confirmed by 
blocking  their  reactivities  with  specific 
mAbs, while the Mls-1 reactivity of X17 is 
caused by VI36 expression (not shown). 
nized by the  CDl-reactive  hybridomas were TAP depen- 
dent  (representative  examples  are  shown  in  Fig.  9).  This 
was true whether  or not their expression was dependent  on 
[32m. 
Heterogeneity of the CDl-reactive Hybridomas.  Given  the 
high frequency  of CDl-reactive  clones among  the autore- 
active CD4 + cells in II  ~ mice, two questions  arose.  (a) Did 
these  cells  display a  monomorphic  specificity,  perhaps  ac- 
companied  by  a  constrained  TCR  repertoire?  (b)  Is  the 
CD1  target  recognized  by  itself or  in  conjunction  with 
other molecules: peptides such as classical MHC  molecules, 
or lipids as recently reported  (46)? 
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Figure  7.  Recognition of a [32m-dependent ligand 
by  several of the  autoreactive hybridomas from  IF 
mice.  Broadly reactive hybridomas were stimulated 
with spleen cells from 152m  ~ and wild-type littemlate 
mice. Splenic APCs were added in serial twofold dilu- 
tions, from a maximum at 4 ￿  10  s cells per well. 
The heterogeneity of the hybridomas was evaluated by a 
number of criteria,  as summarized  in Fig.  10.  TCR  V  re- 
gion sequencing showed diverse  usage of V[3 and Vc~ re- 
gions, with variable CDR3 lengths and amino acid compo- 
sitions  (not  shown).  It  may  be  worth  emphasizing  that 
none  of our  CDl-reactive  hybridomas  expressed  the  in- 
variant VJ314-JJ315 sequence characteristic ofNKl.l  CD4 + 
cells (37), as detemined by reverse transcription PCR with 
VI314-specific primers (not shown). 
Heterogeneity  was  more  evident  in  the  responses  to 
stimulation  by  APCs  from  different  mutant  or  inbred 
mouse  strains.  As  mentioned  above  (Fig.  7),  two  of the 
seven CDl-reactive  hybridomas were capable of respond- 
ing to APCs from [32m  ~ mice. The txMT knockout muta- 
tion,  which  abrogates  B  cell  development  (6),  prevented 
splenic APCs from stimulating two other hybridomas, indi- 
cating that B  cells  are necessary presenting cells in these in- 
stances. As already indicated in Fig. 6, most of the hybrido- 
mas responded to all of the nonmutant common laboratory 
strains.  Clone  VIII82,  however,  reacted  very  poorly  to 
APCs from BALB/c mice,  even  though B6 and  BALB/c 
mice have essentially identical CDI.1 molecules and CD1.2 
molecules that differ only by one amino acid (47,  48).  Fi- 
nally, we tested the hybridomas against splenic APCs from 
various  subspecies  of Mus  (Fig.  10).  Here  again,  the  re- 
sponses led to splits.  These  results  clearly indicate  that the 
CDl-specific  hybridomas  are  heterogeneous  and  do  not 
recognize one simple ligand. 
Discussion 
A  Diverse but  Distinct  Population.  Our  analysis  of the 
CD4 +  T  lymphocytes found in the  periphery  of II  ~  mice 
indicated that these cells share many characteristics with the 
major CD4 + T  lymphocyte subset found in normal animals. 
By several criteria, the dynamics of the two populations ap- 
peared similar:  ontogeny, thymic input,  and  division rate. 
Furthermore,  the  two  seemed  to  have  comparable  func- 
tional  potentials:  they were  stimulated  to  about  the  same 
degree with polyclonal reagents, secreted lymphokines, and 
they proliferated upon activation and provided "help" to B 
cells.  Finally,  both  populations  displayed  a  diverse  reper- 
toire of TCRs. 
Nevertheless,  the  CD4 +  population  from II  ~ mice  dis- 
played some special features. These cells localized preferen- 
tially to the B rather than T  cell areas in the peripheral lym- 
phoid organs  (1).  Perhaps,  most strikingly,  the majority of 
them expressed  cell surface markers  reminiscent  of resting 
memory cells,  while  in normal mice,  only  10-20% of the 
CD4 +  T  lymphocytes show this  phenotype.  Also atypical 
was  their  capacity  to  produce  high  amounts  of lympho- 
kines,  particularly  IL-4,  upon  activation.  Lastly,  although 
the  II  ~ CD4 +  cells,  like their  II  +  counterparts,  displayed a 
diverse  TCR  repertoire,  this  repertoire  did  exhibit  some 
particularities,  notably  altered  levels  of certain  VJ3s and  a 
dearth of Vex2 + receptors. 
Altogether,  one is left with  the impression  of a popula- 
tion sharing many features with the normal CD4 + T  lym- 
phocyte population, yet not identical to it. We do not for- 
mally  know  whether  these  cells  are  a  peculiarity  of II  ~ 
mice. They have not so far been identified in normal mice 
but could just be masked by the bulk CD4 + T  cell popula- 
tion. 
The  CD4 +  cells  from  II  ~ mice were  also  distinct  from 
the  unusual  population  of NKI.1 +  mature  CD4+8  and 
CD4-8-  thymocytes  and  peripheral  T  lymphocytes  dis- 
covered several years ago (35, 36). An enriched proportion 
of these  cells  displays V[38 + TCRs,  and almost all of them 
exhibit an invariant TCR-ot chain, V[314-J15 (29, 30, 35- 
37). The majority shows a cell surface phenotype similar to 
memory cells,  particularly high levels of CD44 + expression 
(29).  NK1.1 + lymphocytes are the major lymphokine-pro- 
ducing cells in the thymus (49-51), and peripheral NKI.1 + 
cells  have recently been recognized as major producers  of 
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Figure 9.  Differential TAP dependence  of the class Ib ligands. Hybri- 
doma cells were stimulated with splenic APC from TAP-1  ~ and TAP-1 + 
littermate  mice. Splenic APCs were added as described in Fig. 7. While 
the Qa-1  recognized by VII11 was dependent on the presence of TAP-1 
in the APCs,  all CDl-reactive hybridomas were TAP independent;  only 
a representative three are shown here. 
Figure 8.  Activation by CD1 of most of the autoreactive  hybridomas. 
Hybridomas were stimulated with transfectant cell hnes expressing the in- 
dicated class Ib molecules and the respective untransfected  controls.  The 
stimulation  obtained  with B6 splenocytes was used as a reference  value, 
and the responses to the transfectants are expressed as percentages of the 
response to B6 APC. The background  value (-) obtained  with the non- 
transfected control APC is shown. 
IL-4 (52).  The NKI.1 +  cells do not depend on MHC  class 
I[ molecules for selection/expansion,  but rather  on expres- 
sion of [~2m (or MHC  class I molecules)  on bone marrow- 
derived cells (31-34).  The  CD4 + population  from II  ~ mice 
does contain  a  component  ofNKl.1  §  cells; however,  this 
is  relatively  minor,  ~20-30%,  with  no  enrichment  in 
numbers.  The bulk of the population has some features like 
NK1.1 + cells, notably a memory phenotype and high pro- 
duction  of lymphokines  upon  stimulation,  but  the  differ- 
ences between the two remain evident: a diverse vs restricted 
TCR  repertoire  and  independence  of vs  dependence  on 
expression  of j32m.  It  is possible  that  the  NKI.1 §  CD4 + 
cells are a peculiar subset of the larger CD4 + population we 
have  defined in  II  ~ animals,  perhaps  expanded  in  response 
to a specific stimulus. 
Recognition  of MHC  Class Ib Molecules.  To study the re- 
activities  of  the  CD4 +  lymphocytes  from  II  ~  mice,  we 
turned  to  an  analysis  at  the  clonal  level.  Initially,  we  at- 
tempted to derive antigen-specific hybridomas  (not shown). 
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II  ~  mice  were  immunized  with  various  proteins  in  com- 
plete  Freund's  adjuvant  and  sets  of  hybridomas  derived 
from  purified  CD4 +  cells reactivated  in  vitro.  The  hybri- 
domas  were  challenged  with  the protein  antigen  and  with 
bacterial  antigens  such  as  heat  shock  protein  60  and  puri- 
fied protein derivative from mycobacteria,  and preparations 
of heat-killed mycobacteria and listeria. No response to any 
of these  challenges  was  elicited from  the  hybridomas.  We 
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Figure  10.  Heterogeneity of the  CDl-specific  hybridomas.  Results 
were compiled from several sets of experiments.  Expression  of TCR V 
segments was determined  by sequencing  of the TCR-cl and  -13 chains 
and/or staining.  For two hybridomas,  two in-flame ix chain  sequences 
were found. A second TCR-o~ sequence was found for VII49 with an out 
of flame rearrangement.  Surface expression of the V segment (K chain for 
VIII24 and VII182, [3 chain for VIII24, VII68, and VIII57) was verified by 
staining with V region-specific  antibodies. V~9 expression of VII49 was 
determined  by staining  only.  The  VII57  V~x sequence  is so  far unde- 
scribed, but was tentatively assigned Vix since it had the highest homology 
(~80%)  to  members  of this  Vix family.  The CDl-specific hybridomas 
were  stimulated  with  splenic  APCs from ~32m  ~  B  cell~deficient  mice 
(I.LmT~  wild-type BALB/c mice,  or several subspecies  of Mus.  Black 
boxes, positive reactions; empty boxes, no reaction;  nd, not determined. altered  our strategy,  therefore,  this  time  preparing  a large 
number ofhybridomas after in vitro anti-CD3 activation of 
purified CD4 + cells from II  ~ and II  + mice, and challenging 
them with splenocytes from a panel  of mouse strains.  We 
could identify hybridomas derived from both types of mice 
that  exhibited  anti-MHC  or anti-Mls  reactivities.  Only in 
the case of II  ~ mice, however, did we observe a significant 
percentage of hybridomas that were both auto- and polyre- 
active. 
Focusing on  11  with  this  unusual  pattern  of reactivity, 
we explored their specificities using splenocytes from con- 
genic  and  mutant  mouse strains  and  cells  transfected  with 
MHC  class  I  molecules.  Many of the  hybridomas reacted 
specifically  to  class  Ib  molecules:  one  recognized  Qa-1, 
seven saw CD1, and three recognized unidentified ligands, 
all expressed independently of [32m. 
One is led to ask whether reactivity to nonclassical class I 
molecules reflects the restricting specificity of the majority 
of the CD4 + cells in II  ~ mice, or is just a feature of a minor 
component  of the  population.  Clearly,  a  large  percentage 
of the  autoreactive  hybridomas recognized class  Ib mole- 
cules. But most of them did not show reactivity to any of 
the APCs with which they were challenged.  It is certainly 
possible  that  most  of the  CD4 +  cells  in  II  ~ mice  are  re- 
stricted by class Ib molecules, including CD1, but that they 
react  to  these  molecules  in  forms  that  are  not present  on 
splenocytes,  e.g.,  in  association  with  different  ligands  like 
peptides or lipids. The autoreactive clones could just repre- 
sent  the  higher  affinity  fraction  of a  population  of  Ib- 
restricted cells,  much like rare  class II-autoreactive cells  in 
wild-type mice betray the large  class  II-restricted popula- 
tion. 
CDI  Recognition.  Several  recent  findings  have  pro- 
voked interest  in the class Ib molecule CD1.  It is the only 
antigen-presenting  Ib molecule known to have been con- 
served through evolution, and the homology between spe- 
cies is high (53). Interestingly, CD1  exhibits features similar 
to both  class  I  and  class  II MHC  molecules.  On  the  one 
hand,  the intron/exon  structure  of the  CD1  gene and the 
corresponding  domain  structure  of the  protein  are  like 
those of standard  class  I  genes and molecules,  and there  is 
sequence  homology between  the or3 domain  of CD1  and 
the same domain of classical  class I molecules (54).  On the 
other hand,  the or3 domain of CD1  has a similar degree of 
sequence homology with the  [32 domain  of class  II mole- 
cules  (54),  and  CDI's  cell-type  distribution  (41,  53,  55) 
and antigen presentation pathway appear more characteris- 
tic of class II molecules (44). While murine CDl-restricted 
T  cells  have not yet been described,  several human T  cell 
clones  recognizing  CD1  have  been  isolated  (44,  56-59): 
they are CD4-  CD8-  cells expressing either an ot[3 or y8 
TCFZ.  In one  case,  the  presented  antigen  was  of a  novel 
type, mycolic acid, a unique lipid component of the myco- 
bacterial cell wall  (46).  This observation reopens the ques- 
tion  of whether  CD1  can bind peptides  at  all,  a  question 
previously raised because sequence information suggested a 
very different  structure  in  the  ligand-binding  region  (60) 
and because surface expression  of CD1  appeared indepen- 
dent  of TAP  molecules  (44,  45).  Indeed,  TAP  indepen- 
dence  of murine  CDI  was  confirmed,  at  the  functional 
level in our assay,  and it has recently been demonstrated in 
transfectants  (Teitell,  M.,  et  al.,  manuscript  submitted  for 
publication). 
Our findings  add  several  new features  to  the  emerging 
portrait  of this intriguing class Ib molecule.  First of all,  we 
found  that  CD4 +  T  cells  can  also  show  CD1  reactivity. 
This  may indicate  that CD4  can serve as  a  coreceptor for 
CD1  recognition by direct CD1-CD4 contact.  It has been 
demonstrated that CD8  can bind CD1  (Teitell,  M.,  et al., 
manuscript submitted for publication), but the CD1  (x3 do- 
main similarity to both  class I and II molecules may allow 
promiscuous  binding  to  either  coreceptor molecule.  Sec- 
ondly, we observed significant heterogeneity in the reactiv- 
ity patterns and TC1L usages of the different CDl-reactive 
hybridomas.  This  suggests  that  the  target  ligand  may  be 
composed of more than just the CD1  molecule itself,  per- 
haps  including  peptides,  lipids  (46),  or  other  posttransla- 
tional modifications.  It seems unlikely,  though,  that a lipid 
moiety would  be  recognized by  our  hybridomas because 
the  polymorphism  we  detect  between  very  related  Mus 
subspecies would be difficult to account for in this way. Fi- 
nally, since the  CDl-reactive  hybridomas derive  from the 
small CD4 + population in II  ~ mice, we have the means to 
dissect their function in vivo. Already, we know that they 
do  not  mount  a  response  to  several  multiepitope  protein 
antigens and are incapable of providing full  B cell help, ev- 
idenced by a total lack of germinal centers in II  ~ mice,  no 
matter how or how much one stinmlates them (1).  We are 
left with several pressing questions:  How are these autore- 
active  cells  rendered  and  maintained  innocuous  in  mice? 
What  agents  are  capable  of provoking them?  What  is  the 
functional correlate of their impressive capacity to produce 
IL-4? What cells and molecules are responsible for their se- 
lection/expansion? 
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